William Meekison

1.2k total citations
29 papers, 926 citations indexed

About

William Meekison is a scholar working on Microbiology, Epidemiology and Infectious Diseases. According to data from OpenAlex, William Meekison has authored 29 papers receiving a total of 926 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Microbiology, 22 papers in Epidemiology and 4 papers in Infectious Diseases. Recurrent topics in William Meekison's work include Bacterial Infections and Vaccines (23 papers), Pneumonia and Respiratory Infections (16 papers) and Influenza Virus Research Studies (11 papers). William Meekison is often cited by papers focused on Bacterial Infections and Vaccines (23 papers), Pneumonia and Respiratory Infections (16 papers) and Influenza Virus Research Studies (11 papers). William Meekison collaborates with scholars based in Canada, United States and France. William Meekison's co-authors include Roland Guasparini, Scott A. Halperin, L Barreto, David W. Scheifele, Martin T. Schechter, Richard Mathias, Elaine L. Mills, Francisco Noya, Luis Barreto and Pierre Lavigne and has published in prestigious journals such as American Journal of Public Health, The Journal of Pediatrics and Vaccine.

In The Last Decade

William Meekison

29 papers receiving 876 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William Meekison Canada	16	736	580	231	192	71	29	926
Swei‐Ju Chang United States	13	765 1.0×	648 1.1×	168 0.7×	124 0.6×	56 0.8×	17	891
ChrisAnna M. Mink United States	16	857 1.2×	801 1.4×	176 0.8×	90 0.5×	99 1.4×	27	1.0k
Heinz-J. Schmitt Germany	10	401 0.5×	353 0.6×	124 0.5×	114 0.6×	50 0.7×	15	538
Cynthia Kenyon United States	10	425 0.6×	306 0.5×	133 0.6×	216 1.1×	35 0.5×	21	590
Sarah Collins United Kingdom	19	897 1.2×	405 0.7×	207 0.9×	62 0.3×	50 0.7×	33	1.2k
Joan Bartlett United States	13	946 1.3×	757 1.3×	231 1.0×	257 1.3×	48 0.7×	21	1.1k
Sonia Ribeiro United Kingdom	17	1.2k 1.7×	1.1k 1.9×	264 1.1×	451 2.3×	55 0.8×	36	1.5k
Anna M. Acosta United States	12	306 0.4×	204 0.4×	132 0.6×	104 0.5×	105 1.5×	38	580
Jerry Labadie Netherlands	13	324 0.4×	220 0.4×	127 0.5×	87 0.5×	86 1.2×	22	561
Joanne Wolter Belgium	15	370 0.5×	312 0.5×	144 0.6×	51 0.3×	20 0.3×	16	543

Countries citing papers authored by William Meekison

Since Specialization

Citations

This map shows the geographic impact of William Meekison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Meekison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Meekison more than expected).

Fields of papers citing papers by William Meekison

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Meekison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Meekison. The network helps show where William Meekison may publish in the future.

Co-authorship network of co-authors of William Meekison

This figure shows the co-authorship network connecting the top 25 collaborators of William Meekison. A scholar is included among the top collaborators of William Meekison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Meekison. William Meekison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Halperin, Scott A., Bruce Tapiéro, Marc Dionne, et al.. (2013). Safety and Immunogenicity of a Toddler Dose Following an Infant Series of a Hexavalent Diphtheria, Tetanus, Acellular Pertussis, Inactivated Poliovirus, Haemophilus influenzae Type b, Hepatitis B Vaccine Administered Concurrently or at Separate Visits With a Heptavalent Pneumococcal Conjugate Vaccine. The Pediatric Infectious Disease Journal. 33(1). 73–80. 14 indexed citations

Tapiéro, Bruce, Scott A. Halperin, William Meekison, et al.. (2012). Safety and Immunogenicity of a Hexavalent Vaccine Administered at 2, 4 and 6 Months of Age With or Without a Heptavalent Pneumococcal Conjugate Vaccine. The Pediatric Infectious Disease Journal. 32(1). 54–61. 14 indexed citations

Halperin, Scott A., Shelly McNeil, Joanne M. Langley, et al.. (2011). Tolerability and antibody response in adolescents and adults revaccinated with tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed (Tdap) 4–5 years after a previous dose. Vaccine. 29(46). 8459–8465. 33 indexed citations

Halperin, Scott A., David W. Scheifele, Gaston De Serres, et al.. (2011). Immune responses in adults to revaccination with a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine 10 years after a previous dose. Vaccine. 30(5). 974–982. 37 indexed citations

Langley, Joanne M., Valérie Sales, Allison McGeer, et al.. (2009). A dose-ranging study of a subunit Respiratory Syncytial Virus subtype A vaccine with and without aluminum phosphate adjuvantation in adults ≥65 years of age. Vaccine. 27(42). 5913–5919. 46 indexed citations

Barreto, L, et al.. (2007). Humoral immunity 5 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine. Vaccine. 25(48). 8172–8179. 83 indexed citations

McNeil, Shelly, Francisco Noya, Marc Dionne, et al.. (2007). Comparison of the safety and immunogenicity of concomitant and sequential administration of an adult formulation tetanus and diphtheria toxoids adsorbed combined with acellular pertussis (Tdap) vaccine and trivalent inactivated influenza vaccine in adults. Vaccine. 25(17). 3464–3474. 26 indexed citations

Gold, Ronald, Roland Guasparini, William Meekison, et al.. (2007). Safety and Immunogenicity of a Fully Liquid Vaccine Containing Five‐Component Pertussis‐Diphtheria‐Tetanus‐Inactivated Poliomyelitis‐Haemophilus influenzae Type B Conjugate Vaccines Administered at Two, Four, Six and 18 Months of Age. Canadian Journal of Infectious Diseases and Medical Microbiology. 18(4). 241–248. 11 indexed citations

Scheifele, David W., Scott A. Halperin, Earl Rubin, et al.. (2005). Safety and Immunogenicity of a Pentavalent Combination Vaccine (Diphtheria, Tetanus, Acellular Pertussis, Polio and Haemophilus Influenzae Type b Conjugate) When Administered as a Fourth Dose at 15 to 18 Months of Age. Human Vaccines. 1(5). 180–186. 15 indexed citations

10.

Halperin, Scott A., Bruce R. Smith, Margaret L. Russell, et al.. (2000). Adult formulation of a five component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adults. The Pediatric Infectious Disease Journal. 19(4). 276–283. 63 indexed citations

11.

Scheifele, David W., Scott A. Halperin, Roland Guasparini, et al.. (1999). Extended follow-up of antibody levels and antigen responsiveness after 2 Haemophilus influenzae type b conjugate vaccines. The Journal of Pediatrics. 135(2). 240–245. 8 indexed citations

12.

Halperin, Scott A., David W. Scheifele, Carolyn Pim, et al.. (1999). Comparison of a fifth dose of a five-component acellular or a whole cell pertussis vaccine in children four to six years of age. The Pediatric Infectious Disease Journal. 18(9). 772–779. 38 indexed citations

13.

Mills, Elaine L., Ronald Gold, John Thipphawong, et al.. (1998). Safety and immunogenicity of a combined five-component pertussis-diphtheria-tetanus-inactivated poliomyelitis-Haemophilus b conjugate vaccine administered to infants at two, four and six months of age. Vaccine. 16(6). 576–585. 51 indexed citations

14.

Halperin, Scott A., et al.. (1997). Safety and immunogenicity of two inactivated poliovirus vaccines in combination with an acellular pertussis vaccine and diphtheria and tetanus toxoids in seventeen- to nineteen-month-old infants. The Journal of Pediatrics. 130(4). 525–531. 15 indexed citations

15.

Halperin, Scott A., et al.. (1996). Adverse reactions and antibody response to four doses of acellular or whole cell pertussis vaccine combined with diphtheria and tetanus toxoids in the first 19 months of life. Vaccine. 14(8). 767–772. 45 indexed citations

16.

Scheifele, David W., William Meekison, Roland Guasparini, et al.. (1995). Evaluation of booster doses of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in 18-month-old children. Vaccine. 13(1). 104–108. 14 indexed citations

17.

Gold, Ron S., et al.. (1994). Safety and immunogenicity of Haemophilus influenzae vaccine (tetanus toxoid conjugate) administered concurrently or combined with diphtheria and tetanus toxoids, pertussis vaccine and inactivated poliomyelitis vaccine to healthy infants at two, four and six months of age. The Pediatric Infectious Disease Journal. 13(5). 348–355. 47 indexed citations

18.

Scheifele, David W., Gordean Bjornson, William Meekison, Roland Guasparini, & Leslie A. Mitchell. (1993). Evaluation of Haemophilus influenzae Type B Conjugate Vaccine (Meningococcal Protein Conjugate) in Canadian Infants. Canadian Journal of Infectious Diseases and Medical Microbiology. 5(2). 75–81. 1 indexed citations

19.

Scheifele, David W., Gordean Bjornson, Luis Barreto, William Meekison, & Roland Guasparini. (1992). Controlled trial of Haemophilus influenzae type B diphtheria toxoid conjugate combined with diphtheria, tetanus and pertussis vaccines, in 18-month-old children, including comparison of arm versus thigh injection. Vaccine. 10(7). 455–460. 15 indexed citations

20.

Mathias, Richard, et al.. (1989). The role of secondary vaccine failures in measles outbreaks.. American Journal of Public Health. 79(4). 475–478. 145 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact